Home
About
Overview
Sharing Data
ORCID
Help
History (24)
A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National Cancer Database analysis.
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
Implications of COVID-19 on the General Surgery Match.
Comparative cranial biomechanics in two lizard species: impact of variation in cranial design.
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL). Transl Oncol. 2015 Oct; 8(5):368-375.
View in:
PubMed
authors with profiles
Yusuke Nakamura
Wendy Stock